134 related articles for article (PubMed ID: 36806616)
1. Screening costs associated with donor selection for fecal microbiota transplantation for treatment of PD-1 refractory melanoma patients.
Fortman D; Avellan MGP; Hurd D; Schwartz M; Dubner H; Hewitt C; Berton S; Ernst S; Rose A; Zarour HWH; Davar D
Melanoma Res; 2023 Apr; 33(2):136-148. PubMed ID: 36806616
[TBL] [Abstract][Full Text] [Related]
2. Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial.
Borgers JSW; Burgers FH; Terveer EM; van Leerdam ME; Korse CM; Kessels R; Flohil CC; Blank CU; Schumacher TN; van Dijk M; Henderickx JGE; Keller JJ; Verspaget HW; Kuijper EJ; Haanen JBAG
BMC Cancer; 2022 Dec; 22(1):1366. PubMed ID: 36585700
[TBL] [Abstract][Full Text] [Related]
3. How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantation.
Groenewegen B; van Lingen E; Ooijevaar RE; Wessels E; Feltkamp MCW; Boeije-Koppenol E; Verspaget HW; Kuijper EJ; van Prehn J; Keller JJ; Terveer EM;
PLoS One; 2022; 17(3):e0265426. PubMed ID: 35298520
[TBL] [Abstract][Full Text] [Related]
4. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G
Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602
[TBL] [Abstract][Full Text] [Related]
5. Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and Recommendations.
Khanna S; Tande A; Rubin DT; Khoruts A; Kahn SA; Pardi DS
Mayo Clin Proc; 2021 Jun; 96(6):1418-1425. PubMed ID: 34088413
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of extended-spectrum beta-lactamase organisms and the COVID-19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong.
Yau YK; Mak WYJ; Lui NSR; Ng WYR; Cheung CYK; Li YLA; Ching YLJ; Chin ML; Lau HSL; Chan KLF; Chan KSP; Ng SC
United European Gastroenterol J; 2021 Nov; 9(9):1027-1038. PubMed ID: 34623758
[TBL] [Abstract][Full Text] [Related]
7. Challenges and costs of donor screening for fecal microbiota transplantations.
Bénard MV; de Bruijn CMA; Fenneman AC; Wortelboer K; Zeevenhoven J; Rethans B; Herrema HJ; van Gool T; Nieuwdorp M; Benninga MA; Ponsioen CY
PLoS One; 2022; 17(10):e0276323. PubMed ID: 36264933
[TBL] [Abstract][Full Text] [Related]
8. Faecal microbiota transplantation for
Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive approach to stool donor screening for faecal microbiota transplantation in China.
He J; He X; Ma Y; Yang L; Fang H; Shang S; Xia H; Lian G; Tang H; Wang Q; Wang J; Lin Z; Wen J; Liu Y; Zhai C; Wang W; Jiang X; Xuan J; Liu M; Lu S; Li X; Wang H; Ouyang C; Cao M; Lin A; Zhang B; Wu D; Chen Y; Xiao C
Microb Cell Fact; 2021 Nov; 20(1):216. PubMed ID: 34838016
[TBL] [Abstract][Full Text] [Related]
10. Framework for rational donor selection in fecal microbiota transplant clinical trials.
Duvallet C; Zellmer C; Panchal P; Budree S; Osman M; Alm EJ
PLoS One; 2019; 14(10):e0222881. PubMed ID: 31600222
[TBL] [Abstract][Full Text] [Related]
11. STRUCTURING A FECAL MICROBIOTA TRANSPLANTATION CENTER IN A UNIVERSITY HOSPITAL IN BRAZIL.
Terra DAA; Vilela EG; Silva ROS; LeÃo LA; Lima KS; Passos RIFÂ; Diniz AN; Coelho LGV
Arq Gastroenterol; 2020; 57(4):434-458. PubMed ID: 33331486
[TBL] [Abstract][Full Text] [Related]
12. The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation.
He R; Li P; Wang J; Cui B; Zhang F; Zhao F
Gut Microbes; 2022; 14(1):2100197. PubMed ID: 35854629
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
[TBL] [Abstract][Full Text] [Related]
14. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
[TBL] [Abstract][Full Text] [Related]
15. Challenges of Screening Prospective Stool Donors for Fecal Microbiota Transplantation.
Dubois NE; Read CY; O'Brien K; Ling K
Biol Res Nurs; 2021 Jan; 23(1):21-30. PubMed ID: 32677450
[TBL] [Abstract][Full Text] [Related]
16. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
17. Donor Screening Experience for Fecal Microbiota Transplantation in Patients With Recurrent C. difficile Infection.
Tariq R; Weatherly R; Kammer P; Pardi DS; Khanna S
J Clin Gastroenterol; 2018 Feb; 52(2):146-150. PubMed ID: 27984397
[TBL] [Abstract][Full Text] [Related]
18. Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank.
Ianiro G; Porcari S; Bibbò S; Giambò F; Quaranta G; Masucci L; Sanguinetti M; Gasbarrini A; Cammarota G
Dig Liver Dis; 2021 Nov; 53(11):1428-1432. PubMed ID: 34030988
[TBL] [Abstract][Full Text] [Related]
19. A Matching Strategy To Guide Donor Selection for Ulcerative Colitis in Fecal Microbiota Transplantation: Meta-Analysis and Analytic Hierarchy Process.
Zhang B; Yang L; Ning H; Cao M; Chen Z; Chen Q; Lian G; Tang H; Wang Q; Wang J; Lin Z; Wen J; Liu Y; Xuan J; Li X; Lin A; He J; Zhang L; Hou X; Zeng Q; Xiao C
Microbiol Spectr; 2023 Feb; 11(1):e0215921. PubMed ID: 36472435
[TBL] [Abstract][Full Text] [Related]
20. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
